NewsBenzingaMISE À JOUR : Ocugen T3 BPA ajusté (0,06 $), conforme, ventes de 1,951 M$ dépassant l’estimation de 1,098 M$ MISE À JOUR : Ocugen T3 BPA ajusté (0,06 $), conforme, ventes de 1,951 M$ dépassant l’estimation de 1,098 M$ Benzinga 2026.11.04 15:21 (GMT+0) Open on Benzinga Other news Truist Securities Reiterates Buy on IDEAYA Biosciences, Lowers Price Target to $57 Wells Fargo Maintains Overweight on Fortune Brands, Raises Price Target to $51 Trimble Stock Sinks 18% After Q3 Sales Miss, Cut to GAAP Profit Outlook RBC Capital Maintains Outperform on Aptiv, Lowers Price Target to $64 Truist Securities Maintains Hold on Hagerty, Raises Price Target to $16 Truist Securities Reiterates Hold on Graphic Packaging Holding, Raises Price Target to $10
